Caseware UK (AP4) 2023.0.135 2023.0.135 2023-12-312023-12-31true2023-01-01falseNo description of principal activity207trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 07810487 2023-01-01 2023-12-31 07810487 2022-01-01 2022-12-31 07810487 2023-12-31 07810487 2022-12-31 07810487 c:Director8 2023-01-01 2023-12-31 07810487 d:ComputerEquipment 2023-01-01 2023-12-31 07810487 d:ComputerEquipment 2023-12-31 07810487 d:ComputerEquipment 2022-12-31 07810487 d:ComputerEquipment d:OwnedOrFreeholdAssets 2023-01-01 2023-12-31 07810487 d:CurrentFinancialInstruments 2023-12-31 07810487 d:CurrentFinancialInstruments 2022-12-31 07810487 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 07810487 d:CurrentFinancialInstruments d:WithinOneYear 2022-12-31 07810487 d:RetainedEarningsAccumulatedLosses 2023-12-31 07810487 d:RetainedEarningsAccumulatedLosses 2022-12-31 07810487 c:FRS102 2023-01-01 2023-12-31 07810487 c:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 07810487 c:FullAccounts 2023-01-01 2023-12-31 07810487 c:CompanyLimitedByGuarantee 2023-01-01 2023-12-31 07810487 2 2023-01-01 2023-12-31 07810487 e:PoundSterling 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure
Registered number: 07810487









SURROGACY UK LIMITED
(A Company Limited by Guarantee)

UNAUDITED

FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2023

 
SURROGACY UK LIMITED
 
(A Company Limited by Guarantee)
REGISTERED NUMBER: 07810487

BALANCE SHEET
AS AT 31 DECEMBER 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
  
12,373
-

Current assets
  

Debtors: amounts falling due within one year
 5 
1,323
969

Cash at bank and in hand
 6 
99,778
236,159

  
101,101
237,128

Creditors: amounts falling due within one year
 7 
(12,773)
(9,609)

Net current assets
  
 
 
88,328
 
 
227,519

  

Net assets
  
100,701
227,519


Capital and reserves
  

Reserves
  
100,701
227,519

  
100,701
227,519


The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The the company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



Alan White
Director

Date: 12 September 2024

The notes on pages 2 to 7 form part of these financial statements.
Page 1

 
SURROGACY UK LIMITED

(A Company Limited by Guarantee)
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

1.


General information

Surrogacy UK Limited is a private company limited by guarantee incorporated in England and Wales within the United Kingdom. The registered number is 07810487 and the address of the registered office is 24 Old Bond Street, London, EC2M 1QS.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying SurrogacyUK's accounting policies.
The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to SurrogacyUK and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised.
Membership fees are recognised in the period received. Membership is permanent and is therefore not apportioned over a particular period.
Conference revenue and associated costs are recognised in the period that the conference is held.
Donations are recognised in the period received.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Pensions

Defined contribution pension plan
SurrogacyUK operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which SurrogacyUK pays fixed contributions into a separate entity. Once the contributions have been paid SurrogacyUK has no further payment obligations.
The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from SurrogacyUK in independently administered funds.

Page 2

 
SURROGACY UK LIMITED

(A Company Limited by Guarantee)
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the SurrogacyUK operates and generates income.

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Computer equipment
-
over 3 years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

 
2.9

Creditors

Short-term creditors are measured at the transaction price.
Page 3

 
SURROGACY UK LIMITED

(A Company Limited by Guarantee)
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.10

Financial instruments

The company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's Balance Sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting date. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is
Page 4

 
SURROGACY UK LIMITED

(A Company Limited by Guarantee)
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

2.Accounting policies (continued)


2.10
Financial instruments (continued)

due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.


3.


Employees

2023
2022
£
£

Wages and salaries
193,056
58,303

Social security costs
5,209
-

Cost of defined contribution scheme
4,549
1,038

202,814
59,341


The average monthly number of employees, including directors, during the year was 20 (2022 - 7).

Page 5

 
SURROGACY UK LIMITED

(A Company Limited by Guarantee)
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

4.


Tangible fixed assets





Computer equipment

£



Cost or valuation


Additions
17,132



At 31 December 2023

17,132



Depreciation


Charge for the year on owned assets
4,759



At 31 December 2023

4,759



Net book value



At 31 December 2023
12,373



At 31 December 2022
-


5.


Debtors

2023
2022
£
£

Prepayments and accrued income
1,323
969



6.


Cash and cash equivalents

2023
2022
£
£

Cash at bank and in hand
99,778
236,159


Page 6

 
SURROGACY UK LIMITED

(A Company Limited by Guarantee)
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

7.


Creditors: Amounts falling due within one year

2023
2022
£
£

Trade creditors
2,076
1,247

Corporation tax
2,137
-

Other taxation and social security
2,560
-

Accruals and deferred income
6,000
8,362

12,773
9,609



8.


Reserves

Reserves represents any surplus to be reinvested into our community and to raise public awareness of surrogacy as an inclusive, accessible pathway to parenthood.



9.


Company status

SurrogacyUK is a private company limited by guarantee and consequently does not have share capital. Each of the members is liable to contribute an amount not exceeding £1 towards the assets of the company in the event of liquidation.


10.


Pension commitments

SurrogacyUK operates a defined contributions pension scheme. The assets of the scheme are held separately from those of SurrogacyUK  in an independently administered fund. The pension cost charge represents contributions payable by SurrogacyUK  to the fund and amounted to £4,549 (2022 - £1,038). Contributions totalling £Nil (2022 - £Nil) were payable to the fund at the balance sheet date.


Page 7